Home > Insider Trading > Filing (0000933430-21-000005)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1539029	Clearside Biomedical Inc.	CLSD	()	IL

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
933430	T Bradford Whitmore	1603 Orrington Ave., Ste 900 Evanston IL 60201		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-08-30	99,400	$7.06	2,735,941	No	4	S	Indirect	by Grace Brothers, LP
Common Stock	Disposition	2021-08-31	107,682	$6.96	2,628,259	No	4	S	Indirect	by Grace Brothers, LP
Common Stock	Disposition	2021-09-01	213,203	$6.89	2,415,056	No	4	S	Indirect	by Grace Brothers, LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	by Grace Brothers, LP
No	4	S	Indirect	by Grace Brothers, LP
No	4	S	Indirect	by Grace Brothers, LP

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,529,845	Direct

Footnotes

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.97 to $7.42. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.
As General Partner of Grace Brothers, LP, Bradford T. Whitmore is an indirect beneficial owner of 2,415,056 shares of Common Stock.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.8499 to $7.21. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.66 to $7.09. The reporting person undertakes to provide, upon request by the staff of the SEC, the issuer, or a security holder of the issuer, full information regarding the number of shares transacted at each price, with respect to all transactions reported on this Form 4.